Lifecycle
Selection
Reviews
2018
2024
2030
2036
2042
2048
2054
2060
2066
4.5 years
Discovery
5.5 years
Pre
-
clinical
26.5 years
Clinical Trials
12.5 years
Licensing Approval
Availability
2018
-
2022
10K Candidates
2022
-
2028
20 Candidates
2028
-
2035
10 Candidates
2035
-
2043
2
-
5 Candidates
2043
-
2054
1
-
2 Drug Candidates
2054
-
2067
1 Drug
Phase 1 Review
Dec 2034
Phase 2 Review
Jul 2043
Phase 3 Review
Jul 2054
Approval
Jan 2067
NDA Submission
Dec 2027
IND Submission
Jun 2022
Drug Selection
Feb 2019